Heart Disease News and Research

Latest Heart Disease News and Research

Commitment to good investments, ability to say 'no' at heart of foreign aid reform

"During these tough budget times, citizens across the world rightfully question the effectiveness of government spending, including funds spent on foreign assistance," Daniel Yohannes, chief executive officer of the Millennium Challenge Corporation (MCC), writes in this Foreign Policy opinion piece.

27 Sep 2012

Pfizer, Bristol-Myers Squibb report FDA acknowledgement of ELIQUIS NDA resubmission

Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the New Drug Application (NDA) resubmission for ELIQUIS (apixaban) to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF).

27 Sep 2012

STENTYS announces European commercial release of new Self-Apposing stent technology

STENTYS, a medical technology company commercializing the world's first and only self-apposing stent to treat Acute Myocardial Infarction (AMI), announced today the European commercial release of an enhanced stent-delivery system for its Self-Apposing stent.

27 Sep 2012

Karolinska Institutet scientists discover new approach to treat type II diabetes

An international team of scientists, led from Karolinska Institutet in Sweden, have discovered an entirely new approach to the treatment of type II diabetes. The therapy involves the blockade of signalling by a protein known as VEGF-B and this prevents fat from accumulating in the 'wrong' places, such as in muscles and in the heart. As a result the cells within these tissues are once again able to respond to insulin.

27 Sep 2012

Prime Healthcare Services purchases Dallas Medical Center

Prime Healthcare Services announced today that it has purchased Dallas Medical Center, located in Dallas, Texas.

27 Sep 2012

Henry Ford Hospital opens new Center for Cancer Surgery

With more patients seeking cancer treatment – especially surgery – than ever before, Henry Ford Hospital has opened the new Center for Cancer Surgery.

27 Sep 2012

Deficit continues to be test for Obama -- with debate about Medicare and Medicaid central to both campaigns

The New York Times reports that with the deficit over $1 trillion, President Barack Obama and GOP presidential pick Mitt Romney propose different prescriptions, especially regarding government health programs. Meanwhile, the Wall Street Journal reports on how health firms are preparing for possible election outcomes.

27 Sep 2012

Enrollment complete in Resverlogix‘s RVX-208 Phase 2b trial on cardiovascular disease

Resverlogix Corp. today announced that it has completed enrollment in ASSURE, a Phase 2b clinical trial targeting high-risk cardiovascular disease patients.

27 Sep 2012

CSL develops new drug candidate against type 2 diabetes

CSL Limited has developed a new drug candidate that is able to prevent the development of type 2 diabetes and reverse its progression in animal models of the disease.

27 Sep 2012

Concern grows about rice-related arsenic exposure

US children who consume rice have significantly higher levels of urinary arsenic than children who do not, show study results.

26 Sep 2012

Bipolar patients do not show accelerated cognitive decline

Elderly patients with bipolar disorder do not show greater levels of cognitive decline over 2 years than their mentally healthy counterparts, research suggests.

26 Sep 2012

Eat fruit and veggies to prevent heart attack, women told

A diet that is high in antioxidants can reduce the risk for myocardial infarction in women, a study suggests.

26 Sep 2012

MindChild receives FDA pre-market clearance for MERIDIAN non-invasive fetal heart monitor

MindChild Medical, Inc. today announced that it has received clearance for its Pre-Marketing Notification (510(k)) from the US Food and Drug Administration (FDA) for its MERIDIAN non-invasive fetal heart monitor.

26 Sep 2012

First Edition: September 26, 2012

Today's headlines include a reports about a round of new polls sizing up the status of the presidential campaign as well as one from The Associated Press measuring public opinion about the implementation of the health law.

26 Sep 2012

Dual cigarette and waterpipe users more likely to develop dependence, tobacco-related diseases

People who smoke both cigarettes and waterpipes - dual users - lack sufficient knowledge about the risks of tobacco smoking and are at considerable risk for dependence and tobacco-related diseases, such as cancer, heart disease and stroke later in life, according to findings of a new study by Virginia Commonwealth University.

26 Sep 2012

Ambulatory BP monitoring can accurately measure hypertension epidemic

A recently published editorial in the Journal of the American Society of Hypertension (JASH), "Ambulatory Blood Pressure Monitoring Should Be Included in the National Health and Nutritional Examination Survey (NHANES)," recognizes the importance of this national survey instrument but questions the efficiency of its diagnostic methods in assessing hypertension in the population.

26 Sep 2012

PsiOxus initiates ColoAd1 phase I/II trial in metastatic solid tumours

PsiOxus Therapeutics, Ltd. has treated the first patient in its phase I/II clinical trial of ColoAd1for the treatment of metastatic solid tumours.

26 Sep 2012

Viewpoints: The 'real story' of Ryan at AARP; 'Get thee to an emergency room'

The headlines this weekend were all about the boos Paul Ryan elicited on Friday when he addressed the AARP, the self-styled seniors' lobby. The herd of independent media minds missed the real story, which is that the Republican Vice Presidential nominee went into the heart of the entitlement culture, told some hard truths, and even won applause for doing so.

26 Sep 2012

Researchers identify several kinase inhibitors that help generate many iPSCs

The process researchers use to generate induced pluripotent stem cells (iPSCs)-a special type of stem cell that can be made in the lab from any type of adult cell-is time consuming and inefficient. To speed things up, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) turned to kinase inhibitors.

26 Sep 2012

MHI cardiologists use Montreal technology to treat atrial fibrillation

A team of cardiologists from the Montreal Heart Institute (MHI) specializing in cardiac arrhythmias has used for the very first time in Canada, a technology developed in Montreal to treat a patient with atrial fibrillation. Recently licenced by Health Canada, this sophisticated device is a balloon inserted by catheter that uses extreme cold to burn malfunctioning heart tissue.

From Medtronic 26 Sep 2012

Heart Disease News and Research

Latest Heart Disease News and Research

Commitment to good investments, ability to say 'no' at heart of foreign aid reform

Pfizer, Bristol-Myers Squibb report FDA acknowledgement of ELIQUIS NDA resubmission

STENTYS announces European commercial release of new Self-Apposing stent technology

Karolinska Institutet scientists discover new approach to treat type II diabetes

Prime Healthcare Services purchases Dallas Medical Center

Henry Ford Hospital opens new Center for Cancer Surgery

Deficit continues to be test for Obama -- with debate about Medicare and Medicaid central to both campaigns

Enrollment complete in Resverlogix‘s RVX-208 Phase 2b trial on cardiovascular disease

CSL develops new drug candidate against type 2 diabetes

Concern grows about rice-related arsenic exposure

Bipolar patients do not show accelerated cognitive decline

Eat fruit and veggies to prevent heart attack, women told

MindChild receives FDA pre-market clearance for MERIDIAN non-invasive fetal heart monitor

First Edition: September 26, 2012

Dual cigarette and waterpipe users more likely to develop dependence, tobacco-related diseases

Ambulatory BP monitoring can accurately measure hypertension epidemic

PsiOxus initiates ColoAd1 phase I/II trial in metastatic solid tumours

Viewpoints: The 'real story' of Ryan at AARP; 'Get thee to an emergency room'

Researchers identify several kinase inhibitors that help generate many iPSCs

MHI cardiologists use Montreal technology to treat atrial fibrillation

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Heart Disease News and Research

Latest Heart Disease News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in